Stay updated on Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial
Sign up to get notified when there's something new on the Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial page.

Latest updates to the Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedPublications are now described as automatically filled from PubMed and may not all relate to the study. The revision label changed from v3.2.0 to v3.3.2 and certain publication-related items (e.g., 'clinical study report synopsis', 'AbbVie', 'Helpful Links Provided by') were removed.SummaryDifference0.3%

- Check23 days agoChange DetectedRemoved the government funding status notice and added a clinical study report synopsis, sponsor AbbVie information, and a 'Helpful Links Provided by AbbVie' section.SummaryDifference0.5%

- Check37 days agoChange DetectedOnly minor visual/layout variations appear between the screenshots, with no substantive changes to the study details. No new information was added and no information was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check51 days agoChange DetectedRemoved a link/reference line about 'Helpful Links Provided by AbbVie clinical study report synopsis' without adding alternatives.SummaryDifference0.3%

- Check58 days agoChange DetectedAdded a new 'Helpful Links' resource linking to AbbVie clinical study report synopsis.SummaryDifference0.3%

- Check66 days agoChange Detected- Added a government funding notice with operating status guidance and new links; - Updated version to v3.2.0; - Removed the previous v3.1.0 revision.SummaryDifference3%

Stay in the know with updates to Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial page.